The Australian Academy of Health and Medical Sciences elects the best and brightest minds in the field of medical and health sciences as Fellows.

Fellows are elected in recognition of their outstanding achievements and exceptional contributions to the sector. The Fellowship are acknowledged for their clinical, non-clinical, leadership, industry and research contributions.

About Fellowship with AAHMS

Find Fellows of the AAHMS

To find Fellows of our Academy either use the search form below or download the full list of current Fellows here.






John Curtin Distinguished Professor of Epidemiology
Curtin University

Professor Lin Fritschi is a cancer epidemiologist and public health physician with specific expertise in occupational causes of cancer. Her research revolves around two themes: identifying occupational causes of cancer and improving methods for assessing occupational exposure in epidemiological studies. She has a substantial track record of publications, grants and impact on policy, has successfully mentored and trained junior researchers and has developed key collaborations nationally and internationally.

Professor Fritschi has developed a new online resource for assessing occupational exposure (OccIDEAS), which has been used to assess exposure in studies in Australia, Bhutan, Malaysia, China, the UK and in current studies in NZ and across the EU.

Professor of Clinical Pharmacology
The University of Sydney

Professor Nicholas Buckley’s research focusses on toxicology and adverse effects of drugs, pesticides and snakebite using a range of methods including systematic reviews, clinical trials, drug development, public health interventions, pharmaco-epidemiology and policy analysis, leading to over 300 articles in refereed journals.

Many of Professor Buckley’s research findings have translated into changed practice and improved outcomes, aided by key leadership roles: Chair of the Australian Medicines Handbook Editorial Advisory board, Chair of Toxicology and Toxinology Australian Therapeutic Guidelines panel, Membership of the Advisory Committee on Safety of Medicines (2009-2016) and by being a consultant Clinical Toxicologist to several Poisons Information Centres.




Professorial Fellow
The University of Melbourne

Professor Mary Galea’s basic and clinical research program has contributed substantially to the global quest to understand how to promote repair, regeneration and recovery of the nervous system after injury. Her seminal contributions to understanding the organisation and response to injury of the corticospinal pathways in animal models have been translated into the development of novel interventions to promote functional recovery after spinal cord injury and other nervous system disorders.

Professor Galea built research capacity in physiotherapy at a time when research in this discipline was sparse. Her sustained academic leadership in her profession has been acknowledged with the award of an Order of Australia.

ResMed Chair in Sleep Medicine
The University of Sydney

Professor Peter Cistulli is recognised nationally and internationally as a clinical and research leader in the field of Respiratory and Sleep Medicine. He has made major contributions to the understanding of the causes and treatment of common sleep disorders, such as Obstructive Sleep Apnoea (OSA). His pioneering work on novel therapies, and particularly oral appliances for the treatment of OSA, has changed clinical practice in the field and has contributed to the development of a new interdisciplinary field of Dental Sleep Medicine, bridging medicine and dentistry.

Through distinguished contribution to clinical practice, research and teaching, Professor Cistulli has advanced his field.

Professor of Ophthalmology
Lions Eye Institute

Professor Ian Constable is an internationally recognised clinical and research ophthalmologist. As the Founding Director of the Lions Eye Institute, he created a not-for-profit centre of excellence that combines world-class scientific research into the prevention of blindness with the highest level of eye care delivery. He has trained and mentored almost 100 clinical and research Fellows from all over the world and has provided an environment to conduct research at the highest international standards.

Professor Constable’s work has been instrumental in some significant developments in ophthalmology, including an artificial cornea and a first in human gene therapy trial for exudative Macular Degeneration.


Scientia Professor
UNSW Sydney

Professor Guy Marks is a world-leading respiratory physician and epidemiologist, whose outstanding contributions to the fields of asthma, chronic lung disease, tuberculosis (TB) and air pollution have transformed the national and global responses to these health problems. His sustained research through the Woolcock Institute of Medical Research has been recognised by major awards from the NHMRC, the Thoracic Society, the Ingham Institute and UNSW Sydney.

Professor Marks has made important contributions to training and policy development in lung health and TB control in Australia and internationally. His sustained leadership within the International Union Against TB and Lung Diseases led to his appointment as President in 2019.

Senior Group Leader
The Francis Crick Institute

Professor Carola Vinuesa’s research has contributed to understanding the pathogenesis of autoimmune diseases. She defined the nature of T cell help for B-cells, establishing that follicular helper T (TFH) cells, rather than TH2-cells, are required for antibody production. She also discovered that TFH dysregulation causes autoimmunity, and that TFH cell function is modulated by a unique subset of regulatory T-cells: TFR cells. More recently she uncovered an important role for rare coding gene variants in human systemic autoimmunity.

Professor Vinuesa’s TFH/TFR discoveries are being translated into improving vaccination, eliminating HIV reservoirs, preventing transplant rejection, and treating autoimmunity, immunodeficiency, cancer and allergies.

Consultant Medical Oncologist and Group Leader, Cancer Biology and Therapeutics Program; Professor, Centre for Cancer Research, University of Melbourne
Peter MacCallum Cancer Centre

Professor Sarah-Jane Dawson is a clinician scientist who has consistently demonstrated excellence, leadership and dedicated service to health and medical research in Australia. Professor Dawson’s research has pioneered fundamental advances in the clinical application of cancer genomics and the development of personalised biomarker approaches using circulating tumour DNA. This body of work has led to the rapid expansion of research in this field and established a new paradigm for molecular disease monitoring in cancer.

Professor Dawson continues to demonstrate an ongoing commitment to advancing healthcare through the translation of her discoveries into the clinical arena to improve survival outcomes for cancer patients.

Chair of Clinical Pharmacology
The University of Newcastle

Professor Jennifer Martin is dual-trained clinical pharmacologist and physician based in Newcastle. Through combining her clinical practice with a strong program of research, she has driven clinical impact through knowledge translation and informing effective government policy and regulation with evidence-based research. Her research spans the full translational pathway, from discovery and animal development work, to Phase I-IV clinical trials, and implementation of research into the therapeutic setting.

Professor Martin is considered a leader in her field and is an expert advisor to the health and pharmaceutical sector, industry and various governments, particularly in the area of drug development and pharmaceutical regulation.

Director of Neurophysiology
Westmead Hospital

Professor Steve Vucic is a clinical academic and internationally recognised researcher in the field of neuroscience with an emphasis on understanding amyotrophic lateral sclerosis (ALS) pathogenesis. His key discoveries relating to identification of “cortical hyperexcitability” as an important pathophysiological mechanism in ALS have transformed the understanding of ALS, resulted in novel therapeutic approaches and led to development of pharmacodynamic biomarkers. In addition, a much-needed diagnostic investigation was developed for ALS, termed threshold tracking transcranial magnetic stimulation (TMS), enabling earlier diagnosis and thereby recruitment into clinical trials.

Professor Vucic has published and presented extensively and has received national and international accolades for his research.

Our Fellows sit at the heart of everything we do. They represent Australia’s leading minds in health and medical sciences, having been recognised for their clinical, non-clinical, leadership, industry and research contributions.

To be considered for election to the Academy’s Fellowship, a candidate must show exceptional professional achievement in a field related to health and/or medicine.

Fellows contribute to the projects and activities of the Academy and must be willing to be active participants.

Successful Fellowship candidates will have shown:

  • Outstanding leadership in their field.
  • Significant and ongoing involvement with issues of health care, prevention of disease, education, research, and health services policy and delivery.

Candidates for Fellowship should meet the following criteria:

  • National and International recognition for excellence in health and medical science
  • Significant, sustained and ongoing contributions to advance health and medical science in Australia (relative to opportunity)
  • Contribution to the profession through leadership and mentorship
  • Raised public understanding and promoting health and medical science in the broader community

Download criteria for Fellowship

Each year, current Fellows of the Academy are invited to nominate up to four new candidates who meet the criteria and fulfil the required expectations.

Nominations by a Fellow of two new candidates must ensure that at least one nomination is a woman. Nominations by a Fellow of four new candidates must ensure that at least two nominations are women.

How to make a nomination

Fellows wishing to nominate a candidate for Fellowship should contact the secretariat to confirm candidate eligibility and receive and instructions on how to submit the completed nomination documentation online. 

Fellows wishing to nominate a candidate for a Corresponding Fellowship should contact the secretariat for more information.

Secretariat contact details
Email: [email protected]

Phone: 07 3102 7220

Nomination guidelines for ordinary Fellowship

October 2022
Newly elected Fellows of 2022 are inducted at the Annual Meeting.

Late September 2022-November 2022
Nominations are invited from existing Fellows until the closing date of 30 November.

December 2022
Nominations allocated to Selection Committees.

January – April 2023
Referees’ reports sought.

Early May 2023
Selection Committees meet to consider nominations and provide final recommendations to the Council.

Early-to-mid-July 2023
Council meets to finalise recommendations.

Late July 2023
Full Fellowship invited to comment on recommended new fellows.

August 2023
Election results are shared with proposers and candidates (under embargo).

October 2023
Newly elected Fellows of 2023 inducted at the Annual Meeting.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.